Apellis Pharmaceuticals
Price & Volume
Stats
See moreOpen | $17.30 |
Previous Close | $17.54 |
Day Range | $16.99-$17.59 |
52W Range | $17.01-$49.38 |
Market Cap | $2.2B |
Shares Short | 22M |
Financials
See moreRevenue (12 Mos) | $781.3M |
Revenue Growth (YoY) | 45.2% |
Gross Profit (12 Mos) | $336M |
Diluted EPS | -$1.60 |
News
See moreYahoo Finance • 3 days ago
Is Apellis Pharmaceuticals, Inc. (APLS) Among the Best Guru Stocks to Buy According to Wall Street Analysts?
Yahoo Finance • 25 days ago
Apellis Announces FDA Acceptance and Priority Review of the Supplemental New Drug Application for EMPAVELI® (pegcetacoplan) for C3G and Primary IC-MPGN
Yahoo Finance • 2 months ago
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results
Yahoo Finance • 2 months ago
Apellis Pharmaceuticals to Present at the TD Cowen 45th Annual Health Care Conference
About
CEO | Dr. Cedric Francois M.D., Ph.D. |
CFO | Mr. Timothy E. Sullivan |
Address | 100 Fifth Avenue, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 705 |
